So, I think there needs to be some more conversations and some more data provided to show those pieces. This month, the federal government rolled out its Medicare GLP-1 Bridge program, which makes some weight loss drugs available to eligible users under Medicare Part D drug coverage for $50 a month
Heres a quick comparison of tirzepatide vs semaglutide: Tirzepatide may cause more significant weight loss in clinical trials Semaglutide has been shown to help patients with type 2 diabetes manage blood sugar levels and achieve steady weight reduction Both medications may reduce the risk of major cardiovascular events in people with diabetes The effects of tirzepatide and semaglutide vary based on individual dosage, lifestyle, and your unique weight loss goalswhich is why a personalized approach matters
GLP-1 drugs, especially the next-generation versions, are remarkably effective at helping people lose weight, Krause says
While this may not fully prevent temporary hair loss with Ozempic, Wegovy, Mounjaro or Zepbound
Will this link to knee issues make insurance more likely to approve GLP-1 meds for those of us who dont have diabetes